[1] CHEN W Q, ZHENG R S, BAADE P D, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132. [2] SIEGEL R L, FEDEWA S A, MILLER K D, et al. Cancer statistics for Hispanics/Latinos, 2015[J]. CA Cancer J Clin, 2015, 65(6):457-480. [3] LUO J, CHEN J, HE L. Mir-129-5p attenuates irradiation-induced autophagy and decreases radioresistance of breast cancer cells by targeting HMGB1[J]. Med Sci Monit, 2015, 21:4122-4129. [4] JIANG C X, QU X Y, KE H H, et al. Association between the HMGB1/TLR4 signaling pathway and the clinicopathological features of ovarian cancer[J]. Mol Med Rep, 2018, 18(3):3093-3098. [5] CHEN X L, ZHANG L R, JIANG Y J, et al. Radiotherapy-induced cell death activates paracrine HMGB1-TLR2 signaling and accelerates pancreatic carcinoma metastasis[J]. J Exp Clin Cancer Res, 2018, 37(1):77. [6] GUO X, HE D H, ZHANG E F, et al. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair[J]. J Exp Clin Cancer Res, 2018, 37(1):205. [7] ZHANG T, GUAN X W, GRIBBEN J G, et al. Blockade of HMGB1 signaling pathway by ethyl pyruvate inhibits tumor growth in diffuse large B-cell lymphoma[J]. Cell Death Dis, 2019, 10(5):330. [8] LI P, XU M F, CAI H B, et al. The effect of HMGB1 on the clinicopathological and prognostic features of cervical cancer[J]. Biosci Rep, 2019, 39(5):BSR20181016. [9] LIU W J, ZHANG Z Y, ZHANG Y X, et al. HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway[J]. Cancer Biol Ther, 2015, 16(4):511-517. [10] CHEN J, LIU X Y, ZHANG J, et al. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by Lentivirus-mediated RNA interference[J]. J Cell Physiol, 2012, 227(11):3629-3638. [11] BALD T, QUAST T, LANDSBERG J, et al. Ultravioletradiation-induced inflammation promotes angiotropism and metastasis in melanoma[J]. Nature, 2014, 507(7490):109-113. [12] MENG Q B, ZHAO J, LIU H B, et al. HMGB1 promotes cellular proliferation and invasion, suppresses cellular apoptosis in osteosarcoma[J]. Tumour Biol, 2014, 35(12):12265-12274. [13] 印胡滨, 何卫阳, 苟欣, 等. siRNA干扰HMGB1表达对膀胱癌T24株细胞恶性生物学行为的影响及其可能的机制[J]. 中国肿瘤生物治疗杂志, 2017, 24(3):264-270. [14] YANG X X, MA M, SANG M X, et al. Radiosensitization of esophageal carcinoma cells by knockdown of RNF2 expression[J]. Int J Oncol, 2016, 48(5):1985-1996. [15] ZHAO H, YENARI M A, CHENG D Y, et al. Bcl-2 overexpression protects against neuron loss within the ischemic margin following experimental stroke and inhibits cytochrome c translocation and caspase-3 activity[J]. J Neurochem, 2003, 85(4):1026-1036. [16] WANG Z W, WANG X Y, LI J T, et al. HMGB1 knockdown effectively inhibits the progression of rectal cancer by suppressing HMGB1 expression and promoting apoptosis of rectal cancer cells[J]. Mol Med Rep, 2016, 14(1):1026-1032. |